Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur significant order book increase in a growing market is a great sign of confidence.
Read our latest reportWe are striving to make a valuable contribution to the areas where we operate, alongside our global contribution to supporting the production of low carbon nuclear energy. We wanted to know how we were doing and asked an independent researcher to find out, starting with our UK site, Urenco Capenhurst.
The socioeconomic impact assessment, produced by Oxford Economics, revealed:
Mike Peers, Chief Nuclear Officer, Urenco Capenhurst
Chris Lloyd, Group Chief Nuclear Officer
Laura Johnson, Deputy Communications Manager
We use necessary cookies to make our site work. We'd also like to set analytics cookies that help us make improvements by measuring how you use the site, which are collected in a way that means you cannot be identified.
For more detailed information about the cookies we use, see our Cookies page.
Our privacy policy informs you about how we look after your personal data when you visit our website and explains your privacy rights and how the law protects you.
Cookies are small text files that are placed on your device by websites to collect information about how you browse the site. They do not compromise your privacy or security. For more detailed information about the cookies we use, see our Cookies policy.
These enable things like video, contact forms, search facility and accessibility toolbar. Our third party video player will add cookies to your device that enables it to play the video and collect information like how many plays the video has had.
These help us make improvements by measuring how you use the site, and are collected in a way that means you cannot be identified.